Insider Transactions Reported by 25 Insiders of Royalty Pharma plc

Symbol
RPRX on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Royalty Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pablo G. Legorreta CEO, Chairman of the Board, Director $2,585,100,366 05 Nov 2025
GG 1978 SICAF SIF S.A. 10%+ Owner $608,282,853 14 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic 10%+ Owner $590,239,561 20 Sep 2022
George W. Lloyd EVP, Investments & CLO $280,516,685 -$13,807,997 -4.7% 17 Dec 2025
Terrance P. Coyne Evp & Cfo $234,934,673 -$13,534,004 -5.4% 02 Jan 2026
Mario Germano Giuliani Director, 10%+ Owner $96,010,741 23 Jun 2023
Avara Management Ltd 10%+ Owner $68,463,141 29 Dec 2023
WILLIAM E. FORD Director $56,372,445 30 Jun 2021
Christopher Hite EVP & Vice Chairman $25,701,832 05 Nov 2025
James F. Reddoch EVP & Chief Scientific Officer $23,300,586 28 Sep 2022
Rory B. Riggs Director $11,577,870 20 Feb 2024
Gregory Norden Director $7,059,596 -$1,213,749 -15% 08 Aug 2025
ERROL B. DESOUZA Director $4,828,170 13 May 2025
Henry A. Fernandez Director $4,231,315 30 Jun 2025
Marshall Urist EVP, Research & Investments $3,467,692 -$7,192,970 -67% 09 Jan 2026
Ted W Love Director $3,118,018 13 May 2025
Catherine M. Engelbert Director $2,948,893 13 May 2025
Bonnie L. Bassler Director $2,833,265 31 Dec 2025
DAVID C. HODGSON Director $1,842,120 13 May 2025
Vlad Coric Director $344,996 13 May 2025
ELIZABETH H. WEATHERMAN Director $283,697 31 Jul 2025
Carole Ho Director $283,697 31 Jul 2025
Royalty Pharma plc Director $0 07 Apr 2025
MGG Strategic SICAF SIF S.A. 10%+ Owner 01 Apr 2022
Arthur Richard McGivern EVP, Investments & GC 01 Jan 2026

Recent Insider Transactions by Companies or Individuals for Royalty Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.